Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |